Boehringer Ingelheim – media

Boehringer Ingelheim BioXcellence Expands China Plant, adds Fill-Finish Line.

Boehringer Ingelheim is expanding its $77 million contract biologics China plant, making a notable bet that the kind of contract services it offers elsewhere will be a big draw to China too.
- Source: FiercePharma
- 747
- July 10, 2018
Boehringer Ingelheim Company Insight
After successful pilot, Boehringer Ingelheim, HealthPrize roll out digital adherence tool more broadly

Following a successful nine-month pilot, Boehringer Ingelheim and HealthPrize Technologies announced that the digital adherence support program RespiPoints will be expanded to any patient who is taking certain Boehringer Ingelheim medications, including some available in the Respimat inhaler.
- Source: MobiHealthNews
- 583
- April 20, 2018
Boehringer Ingelheim Company Insights digital health

your submission has already been received.

OK

Subscribe

Please enter a valid Email address！

Submit

The most relevant industry news & insight will be sent to you every two weeks.

more

more

Customer Services
Contact Us
Help Center

Buy on Drugdu.com
Browse Product Categories

Free APP

Follow Us

Terms & Conditions | Privacy Policy

粤ICP备16008861号

Copyright © 2016-2018 Drugdu.com. All Rights Reserved.